Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 4/2017

01-12-2017 | Original Research

Impact of Increased Visceral Fat Measured by CT on Colon Adenocarcinoma Stage

Authors: Ahmad Mahamid, Itamar Ashkenazi, Mika Shapira-Rootman, Oded Olsha, Ricardo Alfici, Eliahu Y Bekhor, Isis Abo- Mouch, Abdel-Rauf Zeina

Published in: Journal of Gastrointestinal Cancer | Issue 4/2017

Login to get access

Abstract

Purpose

Obesity is considered a risk factor for colon cancer. Worse outcome observed in colon cancer patients with obesity may have several mechanisms. However, the influence of obesity on colon cancer stage is yet to be clarified. The objective of this study was to determine the relationship between obesity and stage on presentation.

Methods

This is a retrospective analysis of patients’ files in one university affiliated medical center. Included in this study were non-metastatic patients who underwent colectomy for adenocarcinoma of the colon in whom both the preoperative abdominal computed tomography and the postoperative pathology report were available for evaluation. Abdominal computed tomography measurement of retroperitoneal fat thickness was used as an indicator of obesity. Data was analyzed according to quartiles of fat thickness.

Results

Of 83 patients, 38 were males and 45 were females. Median age was 71 years (range 43–90 years). Increased retroperitoneal fat thickness was not associated with advanced T and N stages on presentation. Rather, patients in the first quartile presented with the worst T and N stages. The proportion of patients with T3 and T4 tumors was 95, 76.2, 66.7, and 66.7% in quartiles 1, 2, 3, and 4, respectively (p = 0.0327), while the proportion of patients with positive lymph node metastasis was 60, 23.8, 23.8, and 42.9% in quartiles 1, 2, 3, and 4, respectively (p = 0.0319).

Conclusions

The data presented here does not support the association of obesity with worse stage at presentation of colon cancer, and other possible mechanisms for worse outcome should be sought.
Literature
2.
go back to reference Edge S, Byrd DR, Compton C,C, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th edition. New York: Springer; 2010. Edge S, Byrd DR, Compton C,C, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th edition. New York: Springer; 2010.
3.
go back to reference Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry Jr CP, Edwards SM. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord. 1998;22:178–84.CrossRefPubMed Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry Jr CP, Edwards SM. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord. 1998;22:178–84.CrossRefPubMed
4.
go back to reference Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD, et al. Body mass index and colon cancer risk in Chinese people: menopause as an effect modifi er. Eur J Cancer. 2006;42:84–90.CrossRefPubMedPubMedCentral Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD, et al. Body mass index and colon cancer risk in Chinese people: menopause as an effect modifi er. Eur J Cancer. 2006;42:84–90.CrossRefPubMedPubMedCentral
5.
go back to reference Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control. 2003;14:75–84.CrossRefPubMed Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control. 2003;14:75–84.CrossRefPubMed
6.
go back to reference Haydon AM, Macinnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006;55:62–7.CrossRefPubMedPubMedCentral Haydon AM, Macinnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006;55:62–7.CrossRefPubMedPubMedCentral
7.
go back to reference Almendingen K, Hofstad B, Vatn MH. Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Am J Gastroenterol. 2001;96:2238–46.CrossRefPubMed Almendingen K, Hofstad B, Vatn MH. Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Am J Gastroenterol. 2001;96:2238–46.CrossRefPubMed
8.
go back to reference DeFronzo RA, Ferrannini E. Insulin resistance—a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atheroschlerotic cardiovascular disease. Diabetes Care. 1991;14:174–94. DeFronzo RA, Ferrannini E. Insulin resistance—a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atheroschlerotic cardiovascular disease. Diabetes Care. 1991;14:174–94.
10.
go back to reference Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Japan Public Health Center-based Prospective Study Group. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer. 2007;120:2007–12.CrossRefPubMed Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Japan Public Health Center-based Prospective Study Group. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer. 2007;120:2007–12.CrossRefPubMed
11.
go back to reference Larsson SC, Rutegård J, Bergkvist L, Wolk A. Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer. 2006;42:2590–7.CrossRefPubMed Larsson SC, Rutegård J, Bergkvist L, Wolk A. Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer. 2006;42:2590–7.CrossRefPubMed
12.
go back to reference Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327–34.CrossRefPubMed Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327–34.CrossRefPubMed
13.
go back to reference Isomura K, Kono S, Moore MA, Toyomura K, Nagano J, Mizoue T, et al. Physical activity and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2006;97:1099–104.CrossRefPubMed Isomura K, Kono S, Moore MA, Toyomura K, Nagano J, Mizoue T, et al. Physical activity and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2006;97:1099–104.CrossRefPubMed
14.
go back to reference House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270–8.CrossRefPubMed House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270–8.CrossRefPubMed
15.
go back to reference Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010;16:1884–93.CrossRefPubMedPubMedCentral Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010;16:1884–93.CrossRefPubMedPubMedCentral
16.
go back to reference Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev. 2012;21(8):1244–59.CrossRef Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev. 2012;21(8):1244–59.CrossRef
17.
go back to reference Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obesity. 2011;15:2011. Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obesity. 2011;15:2011.
18.
go back to reference Keimling M, Renehan AG, Behrens G, Fischer B, Hollenbeck AR, Cross AJ, et al. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study. Cancer Epidemoil Biomarkers Prev. 2013;22(8):1383–94.CrossRef Keimling M, Renehan AG, Behrens G, Fischer B, Hollenbeck AR, Cross AJ, et al. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study. Cancer Epidemoil Biomarkers Prev. 2013;22(8):1383–94.CrossRef
20.
go back to reference Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson 3rd AB, Macdonald JS, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98:484–95.CrossRefPubMed Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson 3rd AB, Macdonald JS, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98:484–95.CrossRefPubMed
Metadata
Title
Impact of Increased Visceral Fat Measured by CT on Colon Adenocarcinoma Stage
Authors
Ahmad Mahamid
Itamar Ashkenazi
Mika Shapira-Rootman
Oded Olsha
Ricardo Alfici
Eliahu Y Bekhor
Isis Abo- Mouch
Abdel-Rauf Zeina
Publication date
01-12-2017
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 4/2017
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9891-8

Other articles of this Issue 4/2017

Journal of Gastrointestinal Cancer 4/2017 Go to the issue